Johnson & Johnson Taiwan Ltd clinical trials

A country office of Johnson & Johnson

The registry lists 23 studies whose lead sponsor is Johnson & Johnson Taiwan Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 4, 2026.

Studies

Recruiting first, then most recently updated. Showing 23 of 23. All Johnson & Johnson studies →

• An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)TerminatedNCT00766402Phase 4

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care TreatmentCompletedNCT00526877Phase 4

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple MyelomaCompletedNCT02268890Phase 4

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With SchizophreniaTerminatedNCT01670071Phase 4

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• Observational Study on the Patients With Pain MedicationsCompletedNCT00771212

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• Study on Migraine and Headache in Epileptic PatientsCompletedNCT00642564

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• A Study on Behavioral and Psychological Symptoms of DementiaCompletedNCT00641459

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable RisperidoneCompletedNCT00644852

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• Pain Satisfaction SurveyCompletedNCT00614861

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00758160Phase 4

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With SchizophreniaCompletedNCT00757705Phase 4

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)CompletedNCT01577186Phase 4

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With SchizophreniaCompletedNCT01577160Phase 4

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical PatientsCompletedNCT01627860Phase 4

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)CompletedNCT00744757Phase 2

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer PainTerminatedNCT00803283Phase 3

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• An Efficacy Study of Combination of Tramadol and Acetaminophen Tablets in the Treatment of Participants With Fibromyalgia PainCompletedNCT00766675Phase 4

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple MyelomaCompletedNCT01801436Phase 3

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne VulgarisCompletedNCT00752635Phase 4

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS)CompletedNCT00460720

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer PatientsCompletedNCT00576173Phase 4

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity DisorderCompletedNCT00518232Phase 4

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd

• Fentanyl for Treatment Pain Caused by RadiotherapyCompletedNCT00523887Phase 4

  Sponsor listed in the registry: Johnson & Johnson Taiwan Ltd